A novel anti-inflammatory drug could help to improve survival in the most severe cases of malaria by preventing the immune system from causing irrevocable brain and tissue damage.Walter and Eliza Hall Institute researchers have shown that a new class of anti-inflammatory agents, called IDR (innate d more
To use all functions of this page, please activate cookies in your browser.
